Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Is Pfizer Stock Underperforming the Nasdaq?

Although Pfizer has underperformed the Nasdaq recently, analysts remain moderately optimistic about the stock’s prospects.

Barchart

Trump Demands Pfizer, Other Covid Drug Makers To 'Justify The Success,' Show Their Results Amid New FDA Restrictions

President Donald Trump has called for pharmaceutical companies to provide evidence of the effectiveness of their COVID-19 drugs.

Benzinga

Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In Works

Former Centers for Disease Control and Prevention immunizations chief Demetre Daskalakis said Sunday he resigned because politics has overrun science at the nation's top public-health agency, warning he "only see[s] harm coming" under Health and Human Services Secretary Robert F. Kennedy Jr.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Who can get updated COVID-19 vaccines in the US now?

FDA has approved COVID shots for people aged 65+ and at high risk; others need a doctor’s order.

Al Jazeera

RFK Jr faces calls to quit as CDC chief fired and senior staff resign: ‘an embarrassment’

Susan Monarez’s ousting and four top resignations follow vaccine confusion, leaving US health agencies in turmoil

The Guardian - US

The Latest: White House says CDC director is fired, agency leaders resign

The director of the nation’s top public health agency is challenging a White House announcement that she's been fired, and several other top leaders of the U.S. Centers for Disease Control and Prevention have resigned, saying President Donald Trump’s administration is putting politics in the way of keeping Americans safe

The Independent UK

FDA approves updated COVID-19 vaccines with new restrictions, potentially limiting access for healthy children

Guidance around COVID-19 vaccines has once again shifted after the Food and Drug Administration on Aug. 27, 2025, approved updated shots for the fall season, but for a more limited group than in prior seasons.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

RFK Jr. Rescinds Emergency Authorizations For COVID-19 Vaccines

Health and Human Services Secretary Robert F. Kennedy Jr. announced on social media that the emergency use authorizations for COVID-19 vaccines have now been rescinded.

Benzinga

FDA approves new Covid-19 vaccines in US but limits who can get them

Agency authorizes shots for those 65 and older, with young people eligible if they have underlying medical conditions

The Guardian - US

Unusual Put Option Activity in Pfizer Stock - Have Investors Turned Bearish?

Barchart reports that Pfizer stock is showing unusual put option activity in yesterday's trading. Does that mean investors have turned bearish? Not necessarily, especially given the company's upgraded guidance.

Barchart

FDA approves updated COVID-19 shots but limits access for some kids and adults

The Food and Drug Administration has approved updated COVID-19 vaccines for the upcoming fall and winter season

The Independent UK

Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months'

The Trump administration is preparing to remove COVID-19 vaccines from the U.S. market "within months," according to a close associate of Health and Human Services Secretary Robert F. Kennedy Jr.

Benzinga

Pediatricians’ association recommends COVID-19 vaccines for toddlers and some older children, breaking with CDC guidance

For 30 years, vaccine recommendations from the Centers for Disease Control and Prevention have aligned closely with those from the American Academy of Pediatrics, or AAP. But on Aug. 19, 2025, the AAP published new vaccine recommendations that diverge from those of the CDC.

The Conversation

3 Defensive Stocks That Can Weather Any Recession

Dividend stocks are often considered safe haven or defensive stocks that can safeguard a portfolio in turbulent times.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Pfizer's Investigational Drug Flunks Late-Stage For Sickle Cell Disease

Pfizer Inc. (NYSE:PFE) on Friday released results from the Phase 3 THRIVE-131 study evaluating inclacumab, an investigational P-selectin inhibitor, in patients 16 years of age and older with sickle cell disease.

MarketBeat

3 Long-Term Dividend Buys You Can Get for Under $50

Discover three undervalued dividend stocks under $50 that offer income, growth potential, and strong total returns for value investors

Barchart

Pfizer Raises Its Guidance and Analysts Up Their Targets - PFE Stock Looks Cheap

Pfizer stock is incredibly cheap following management's raise of its 2025 adjusted earnings per share guidance. It's at just over 8x this year's estimates and 7.8x next year. That's too cheap. Shorting puts works here.

Benzinga

Merck, Pfizer-Backed Therapy Improves Outcomes For Cisplatin-Ineligible Bladder Cancer Patients

On Tuesday, Merck Co. Inc. (NYSE:MRK) released topline results from the Phase 3 KEYNOTE-905 trial (also known as EV-303) in patients with muscle-invasive bladder cancer (MIBC) who are ineligible for cisplatin-based chemotherapy.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply

View Preview

The Guardian - UK

RFK Jr has slashed vaccine research. You need to know how perilous that is for the world

The avian flu virus is now just one mutation away from easier transmission among humans. Trump’s health chief is a grave risk to world health, says Prof Devi Sridhar, chair of global public health at the University of Edinburgh

The Guardian - US

Pfizer Covid vaccine for young children may not be renewed by FDA

Email obtained by Guardian says Pfizer was told approval may not be granted, meaning Moderna may have to fill gap

Evening Standard

FTSE 100 edges down despite hopes of end to Russia-Ukraine war

Evening Standard

GSK to be paid up to £370 million after patent row settles in US

CureVac – a German pharmaceutical company – settled a long-running patent dispute with rival BioNTech and Pfizer in the US on Thursday.

We Got This Covered

Former Trump official calls Kennedy’s latest move a ‘huge strategic misstep’ that ‘deeply compromises national security’

What Kennedy just canceled will terrify you.

Roll Call

HHS phases out mRNA vaccine trials for COVID-19, bird flu - Roll Call

HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine priorities.

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Centers for Disease Control and Prevention

320 stories

Pfizer Inc

315 stories

Health and Human Services

297 stories

the University of Edinburgh

262 stories

239 stories

the Centers for Disease Control and Prevention

238 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.